Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Latest News
    • Siddhivinayak Trust to...

    Siddhivinayak Trust to provide Rs 10 crore for pneumococcal vaccination drive

    Medical Dialogues BureauWritten by Medical Dialogues Bureau Published On 2019-12-29T09:20:12+05:30  |  Updated On 29 Dec 2019 9:20 AM IST

    The Shree Siddhivinayak Ganapati Temple Trust has sanctioned Rs 10 crore for the Maharashtra government’s drive of giving pneumococcal vaccines to the children in tribal areas of the state.


    Mumbai: The vaccination will be carried out in Nandurbar, Palghar, Gadchiroli, Amravati and Nashik for 1.41 lakh children in the age group of 0-1 year


    The Shree Siddhivinayak Ganapati Temple Trust has sanctioned Rs 10 crore for the Maharashtra government’s drive of giving pneumococcal vaccines to the children in tribal areas of the state.


    Chairman of the Trust, Aadesh Bandekar, said this in a statement issued in Mumbai.


    ‘Of the 16 tribal-dominated districts in the state, the first phase of the vaccination will be carried out in Nandurbar, Palghar, Gadchiroli, Amravati and Nashik for 1.41 lakh children in the age group of 0-1 years,’ he said.


    Read Also: Panacea Biotec wins Rs 170 crore Pentavalent vaccine orders from UN agencies


    ‘The vaccine has to be given three times before a child completes nine months. In these five districts, 4.62 lakh vaccine doses are required,’ he said adding that the Trust will provide Rs 10 crore for the purpose.


    The vaccination will help reduce the incidence of pneumonia among the tribal children, the statement said.


    Read Also: Merck Ebola vaccine Ervebo to be available at a lowest access price for poor nations

    Mumbaipneumococcal vaccinesPneumoniaShree Siddhivinayak Ganapati Temple TrustSiddhivinayaktribal areatrustvaccination drivevaccine
    Source : PTI

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Medical Dialogues Bureau
    Medical Dialogues Bureau

      Medical Dialogues Bureau consists of a team of passionate medical/scientific writers, led by doctors and healthcare researchers.  Our team efforts to bring you updated and timely news about the important happenings of the medical and healthcare sector. Our editorial team can be reached at editorial@medicaldialogues.in. Check out more about our bureau/team here

      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok